Alex Biese

June 03, 2023

Participants in the RESTORE study, results of which were presented this weekend at ASCO, saw “significant improvements” in depression and anxiety symptoms after using the Attune app.

June 01, 2023

‘Forwards,’ the new album by Mike Peters and the Alarm, was written while he was hospitalized for treatment of chronic lymphocyte leukemia and pneumonia.

May 26, 2023

Two years after receiving FDA approval, Besremi is a preferred treatment option in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.

May 24, 2023

“Nobody’s going to fight for your life the way you’re going to fight for your life,” Hodgkin’s lymphoma survivor, Paula Ngon, told CURE®.

May 24, 2023

Many cancer centers and nonprofit organizations offer resources for patients with cancer and their caregivers to see the support they need to navigate diagnosis, treatment and survivorship.

May 23, 2023

Campaigns such as #BrewStacheStrong and Melesa’s Wings are uniting brewers and craft beer aficionados as they raise funds and awareness for cancer.

May 23, 2023

Work is underway in the global phase 3 HARMONi study evaluating the combination of ivonescimab and chemotherapy in the treatment of patients with EGFR-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer.

May 19, 2023

Watch Dr. Jyoti Malhotra, from City of Hope Orange County, discuss targeted therapy, during the CURE® Educated Patient® Lung Cancer Summit.

May 18, 2023

Dr. Dawn Mussallem of the Mayo Clinic tells CURE®’s “Cancer Horizons” podcast about how surviving stage 4 non-Hodgkin’s lymphoma and being a heart transplant recipient helps her connect with her patients.

May 18, 2023

Watch an expert discuss biomarker testing during the CURE® Educated Patient® Lung Cancer Summit.

May 17, 2023

Breyanzi has reportedly shown promising effects for patients with relapsed or refractory follicular lymphoma and B-cell non-Hodgkin lymphoma.

May 11, 2023

Depression reduces the likelihood of receiving recommend treatment, which can affect survival, according to a Kentucky-based study of patients with breast cancer.

May 05, 2023

A clinical trial is underway for STX-478, a potential new treatment for breast cancer and other tumors, with initial results expected later this year.

May 03, 2023

TPST-1120 is displaying potential in combatting hepatocellular carcinoma, the fastest-rising cause of cancer-related death in the United States.

April 27, 2023

A team from Rutgers University has figured out the science behind once-dormant, self-reviving cells, and the discovery may help predict which patients will experience relapse.

April 26, 2023

Researchers have found that nothing beats direct attention from a care provider to inspire exercise among young women who have been recently diagnosed with breast cancer.

April 26, 2023

Tislelizumab was found to improve overall survival among patients with advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma.

April 24, 2023

The makers of a new treatment for metastatic, castration-resistant prostate cancer are working to bring it to patients “as quickly as possible.”

April 22, 2023

Watch Dr. Brandon Blue, from Moffitt Cancer Center, discuss health disparities during the CURE Educated Patient Multiple Myeloma Summit.

April 20, 2023

More than 80% of cancer survivors who use cannabis do so for medical reasons, but there remains “a lack of strong evidence” for the drug’s effectiveness, according to the authors of a new study.

April 19, 2023

The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.

April 18, 2023

Acupuncture improved the sleep of cancer survivors faced with chronic pain, opening the door to nonpharmacological methods of sustainable pain management, according to a recent study.

April 06, 2023

Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.